126 related articles for article (PubMed ID: 19106637)
1. Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis.
Brüning A; Burger P; Vogel M; Rahmeh M; Gingelmaiers A; Friese K; Lenhard M; Burges A
Cancer Biol Ther; 2009 Feb; 8(3):226-32. PubMed ID: 19106637
[TBL] [Abstract][Full Text] [Related]
2. Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells.
Brüning A; Vogel M; Burger P; Rahmeh M; Gingelmaier A; Friese K; Lenhard M; Burges A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1309-14. PubMed ID: 19000651
[TBL] [Abstract][Full Text] [Related]
3. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo.
Gills JJ; Lopiccolo J; Tsurutani J; Shoemaker RH; Best CJ; Abu-Asab MS; Borojerdi J; Warfel NA; Gardner ER; Danish M; Hollander MC; Kawabata S; Tsokos M; Figg WD; Steeg PS; Dennis PA
Clin Cancer Res; 2007 Sep; 13(17):5183-94. PubMed ID: 17785575
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib targets the caspase-like proteasome activity in cervical cancer cells, triggering apoptosis that can be enhanced by nelfinavir.
Bruning A; Vogel M; Mylonas I; Friese K; Burges A
Curr Cancer Drug Targets; 2011 Sep; 11(7):799-809. PubMed ID: 21762082
[TBL] [Abstract][Full Text] [Related]
5. Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
Chow WA; Guo S; Valdes-Albini F
Anticancer Drugs; 2006 Sep; 17(8):891-903. PubMed ID: 16940799
[TBL] [Abstract][Full Text] [Related]
6. The integrated stress response promotes B7H6 expression.
Obiedat A; Charpak-Amikam Y; Tai-Schmiedel J; Seidel E; Mahameed M; Avril T; Stern-Ginossar N; Springuel L; Bolsée J; Gilham DE; Dipta P; Shmuel M; Chevet E; Mandelboim O; Tirosh B
J Mol Med (Berl); 2020 Jan; 98(1):135-148. PubMed ID: 31838577
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.
Brüning A; Friese K; Burges A; Mylonas I
Breast Cancer Res; 2010; 12(4):R45. PubMed ID: 20594311
[TBL] [Abstract][Full Text] [Related]
8. Analysis of nelfinavir-induced endoplasmic reticulum stress.
Brüning A
Methods Enzymol; 2011; 491():127-42. PubMed ID: 21329798
[TBL] [Abstract][Full Text] [Related]
9. Antitumour effects of a protease inhibitor, nelfinavir, in hepatocellular carcinoma cancer cells.
Sun L; Niu L; Zhu X; Hao J; Wang P; Wang H
J Chemother; 2012 Jun; 24(3):161-6. PubMed ID: 22759761
[TBL] [Abstract][Full Text] [Related]
10. The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response.
Gupta AK; Li B; Cerniglia GJ; Ahmed MS; Hahn SM; Maity A
Neoplasia; 2007 Apr; 9(4):271-8. PubMed ID: 17460771
[TBL] [Abstract][Full Text] [Related]
11. Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib.
Brüning A; Burger P; Vogel M; Gingelmaier A; Friese K; Burges A
Invest New Drugs; 2010 Oct; 28(5):535-42. PubMed ID: 19554262
[TBL] [Abstract][Full Text] [Related]
12. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
Kim JY; Park YJ; Lee BM; Yoon S
Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902
[TBL] [Abstract][Full Text] [Related]
13. Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway.
Xiang T; Du L; Pham P; Zhu B; Jiang S
Cancer Lett; 2015 Aug; 364(1):79-88. PubMed ID: 25937300
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress.
Pyrko P; Kardosh A; Wang W; Xiong W; Schönthal AH; Chen TC
Cancer Res; 2007 Nov; 67(22):10920-8. PubMed ID: 18006837
[TBL] [Abstract][Full Text] [Related]
15. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
Guan M; Fousek K; Chow WA
FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
[TBL] [Abstract][Full Text] [Related]
16. The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells.
McLean K; VanDeVen NA; Sorenson DR; Daudi S; Liu JR
Gynecol Oncol; 2009 Mar; 112(3):623-30. PubMed ID: 19147209
[TBL] [Abstract][Full Text] [Related]
17. Metformin and epithelial ovarian cancer therapeutics.
Patel S; Kumar L; Singh N
Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765
[TBL] [Abstract][Full Text] [Related]
18. Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
Kraus M; Müller-Ide H; Rückrich T; Bader J; Overkleeft H; Driessen C
Leuk Res; 2014 Mar; 38(3):383-92. PubMed ID: 24418752
[TBL] [Abstract][Full Text] [Related]
19. HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest.
Jiang W; Mikochik PJ; Ra JH; Lei H; Flaherty KT; Winkler JD; Spitz FR
Cancer Res; 2007 Feb; 67(3):1221-7. PubMed ID: 17283158
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
